Your browser doesn't support javascript.
loading
Decision making for anti-VEGF inhibitor continuation: dip stick? or urine protein/creatinine ratio? (VERSiON UP study).
Nakamura, Michio; Funakoshi, Taro; Kataoka, Shigeki; Horimatsu, Takahiro; Nishikawa, Yoshitaka; Matsubara, Takeshi; Mizukami, Takuro; Goto, Tomoyuki; Tsuchihashi, Kenji; Baba, Eishi; Tsumura, Takehiko; Mihara, Yoshiaki; Hamaguchi, Tetsuya; Yanagita, Motoko; Muto, Manabu.
Afiliação
  • Nakamura M; Department of Gastroenterology, Sapporo City General Hospital, 1-1, Kita 11-jo Nishi 13-chome, Chuo-ku, Sapporo, 060-8648, Japan. michio.nakamura@icloud.com.
  • Funakoshi T; Department of Clinical Oncology, Kyoto University Hospital, 54 Shogoin-kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Kataoka S; Department of Clinical Oncology, Kyoto University Hospital, 54 Shogoin-kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Horimatsu T; Department of Clinical Oncology, Kyoto University Hospital, 54 Shogoin-kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Nishikawa Y; Department of Health Informatics, Kyoto University School of Public Health, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, 606-8501, Japan.
  • Matsubara T; Department of Nephrology, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Mizukami T; Department of Clinical Oncology, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki, 216-8511, Japan.
  • Goto T; Department of Gastroenterology, Shiga General Hospital, 4-30, Moriyama-5-chome, Moriyama, 524-8524, Japan.
  • Tsuchihashi K; Department of Hematology, Oncology & Cardiovascular Medicine, Kyushu University Hospital, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
  • Baba E; Department of Oncology and Social Medicine, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
  • Tsumura T; Department of Medical Oncology, Osaka Red Cross Hospital, 5-30 Fudegasakicho, Tennoji-ku, Osaka, 543-8555, Japan.
  • Mihara Y; Department of Medical Oncology, Saitama Medical University International Medical Center, 1397-1, Yamane, Hidaka, 350-1298, Japan.
  • Hamaguchi T; Department of Medical Oncology, Saitama Medical University International Medical Center, 1397-1, Yamane, Hidaka, 350-1298, Japan.
  • Yanagita M; Department of Nephrology, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Muto M; Department of Clinical Oncology, Kyoto University Hospital, 54 Shogoin-kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
BMC Cancer ; 22(1): 515, 2022 May 07.
Article em En | MEDLINE | ID: mdl-35525917
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteinúria / Inibidores da Angiogênese / Fator A de Crescimento do Endotélio Vascular / Neoplasias Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Qualitative_research Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteinúria / Inibidores da Angiogênese / Fator A de Crescimento do Endotélio Vascular / Neoplasias Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Qualitative_research Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article